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Amphetamine Elicits Opposing Actions on Readily
Releasable and Reserve Pools for Dopamine
Dan P. Covey, Steven A. Juliano, Paul A. Garris*
School of Biological Sciences, Illinois State University, Normal, Illinois, United States of America
Abstract
Amphetamine, a highly addictive drug with therapeutic efficacy, exerts paradoxical effects on the fundamental
communication modes employed by dopamine neurons in modulating behavior. While amphetamine elevates tonic
dopamine signaling by depleting vesicular stores and driving non-exocytotic release through reverse transport, this
psychostimulant also activates phasic dopamine signaling by up-regulating vesicular dopamine release. We hypothesized
that these seemingly incongruent effects arise from amphetamine depleting the reserve pool and enhancing the readily
releasable pool. This novel hypothesis was tested using in vivo voltammetry and stimulus trains of varying duration to
access different vesicular stores. We show that amphetamine actions are stimulus dependent in the dorsal striatum.
Specifically, amphetamine up-regulated vesicular dopamine release elicited by a short-duration train, which interrogates the
readily releasable pool, but depleted release elicited by a long-duration train, which interrogates the reserve pool. These
opposing actions of vesicular dopamine release were associated with concurrent increases in tonic and phasic dopamine
responses. A link between vesicular depletion and tonic signaling was supported by results obtained for amphetamine in
the ventral striatum and cocaine in both striatal sub-regions, which demonstrated augmented vesicular release and phasic
signals only. We submit that amphetamine differentially targeting dopamine stores reconciles the paradoxical activation of
tonic and phasic dopamine signaling. Overall, these results further highlight the unique and region-distinct cellular
mechanisms of amphetamine and may have important implications for its addictive and therapeutic properties.
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Introduction
Amphetamine (AMPH) is both addictive, with several notable
episodes of widespread abuse worldwide, and therapeutic, for
treating narcolepsy, attention deficit hyperactivity disorder,
obesity, and traumatic brain injury [1,2]. While there is little
debate that behavioral effects of this important psychostimulant
are associated with a hyperdopamine state [3–6], the underlying
mechanisms by which this condition manifests have been the
subject of intense study. Two, what ostensibly appear to be
mutually exclusive, views have emerged. On the one hand, AMPH
enhances tonic dopamine signaling by reversing dopamine
transporter (DAT) direction, leading to a non-exocytotic, action
potential-independent type of release or ‘‘efflux’’ that is driven by
vesicular depletion and the redistribution of dopamine to the
cytosol [7,8]. On the other hand, AMPH enhances phasic
dopamine signaling by promoting burst firing of dopamine
neurons [9,10], inhibiting dopamine uptake [11,12], and up-
regulating vesicular dopamine release [13,14]. How AMPH
concurrently activates tonic and phasic dopamine signaling, the
two fundamental modes of communication used by dopamine
neurons [15], yet elicits opposing actions on vesicular dopamine
stores is perplexing and unresolved.
Presynaptic neurotransmitter vesicles are functionally and
anatomically segregated into at least three distinct pools, readily
releasable, recycling, and reserve, that are interrogated by
electrical stimulation of short, intermediate, and long duration,
respectively [16]. Distinct vesicular stores have also been proposed
to contribute to exocytotic dopamine release in a stimulus-
dependent manner [17–20]. At the cellular level, AMPH exerts
differential actions on dopamine vesicle populations [21–23].
Moreover, although not systematically evaluated to assess distinct
vesicular stores, AMPH effects on electrically evoked levels of
extracellular dopamine in the striatum in vivo are stimulus-
dependent, with increases revealed by short trains and decreases
by long trains [24,25]. It is thus interesting to speculate that
AMPH depleting the reserve pool drives tonic dopamine signaling
by providing a source of cytosolic dopamine for efflux, but
enhancing the readily releasable pool drives phasic dopamine
signaling by augmenting vesicular dopamine release.
Here we use in vivo voltammetry and vary stimulus duration to
test the novel hypothesis that AMPH elicits opposing actions on
dopamine stores. In support of this hypothesis, we show in the
dorsal striatum that AMPH increased exocytotic dopamine release
evoked by a short train, which interrogates the readily releasable
pool, but decreased release evoked by a long train, which
interrogates the reserve pool. A concurrent augmentation of tonic
and phasic dopamine signaling was also observed. Vesicular
depletion and enhanced tonic signaling appear to be linked
because these effects were specific to AMPH and not cocaine, and
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to the dorsal but not ventral striatum, whereas activation of
vesicular release and phasic signaling generalized across psycho-
stimulants and striatal sub-regions. Our results thus support a
model of AMPH differentially targeting vesicular stores to
reconcile its paradoxical effects on dopamine neurons and identify
regionally distinct actions of this psychostimulant in the striatum
that may relate to its addictive and therapeutic properties.
Methods
Experimental Design
The experimental design is shown in Figure 1. Three durations
of stimulus trains, short (0.4 s), intermediate (2 s), and long (10 s),
were applied to each animal and repeated after administration of
the saline control or drug treatment. A frequency of 60 Hz was
used for all stimulations. Stimulus current was 6300 mA for long
and intermediate trains, and 6125 mA for the short train. The
lower current intensity was selected for the short train to elicit
evoked responses mirroring the amplitude and dynamics of
naturally occurring phasic dopamine transients [26]. As such, we
refer to these responses as ‘‘phasic-like’’. This short train is also
reinforcing in the operant paradigm of intracranial self-stimulation
[27]. Sufficient time was allowed between trains for evoked
responses to recover (5 s per pulse; [28]). Extracellular dopamine
was measured in urethane-anesthetized rats by fast-scan cyclic
voltammetry (FSCV) at a carbon fiber microelectrode (CFM)
implanted in the dorsal and ventral striatum, as described
previously [12]. Vesicular dopamine release was resolved from
dopamine uptake for all evoked responses [28,29]. A low (1 mg/
kg, i.p.) and high (10 mg/kg, i.p.) dose of AMPH was evaluated to
assess dose-dependent effects. A high dose of cocaine (40 mg/kg
i.p.) was evaluated for comparison.
Animals
Adult male Sprague-Dawley rats (,350–400 g), purchased from
Harlan (Indianapolis, IN, USA), were housed under standard
conditions of lighting and temperature. Food and water were
provided ad libitum. Protocols were approved by the Institutional
Animal Care and Use Committee of Illinois State University. Care
was in accordance with NIH guidelines (publication 86–23).
Surgery
Rats were anesthetized with urethane (1.6 g/kg, i.p.) and
immobilized in a stereotaxic frame (David Kopf Instruments,
Tujunga, CA, USA). Deltaphase Isothermal Pads (Braintree
Scientific, Braintree, MA, USA) maintained core temperature
throughout surgery. Burr holes were drilled overlying targeted
regions, dura was removed, and electrodes lowered along a vertical
trajectory using stereotactic coordinates obtained from a brain
atlas based on a flat-skull position [30] and utilizing bregma and
dura as reference points. All coordinates, anteroposterior (AP),
mediolateral (ML) and dorsoventral (DV) are given in mm. The
stimulating electrode targeted the medial forebrain bundle (AP:
24.6, ML: +1.4, DV: 27.0), and a CFM targeted the dorsal (AP:
+1.2, ML: +3.0, DV: 24.5 to 5.0) and ventral (AP: +1.2, ML:
+2.0, DV: 26.5 to 7.5) striatum. The reference electrode, a
chloridized silver wire, was placed in the contralateral superficial
cortex.
Electrochemistry
FSCV was performed by a Universal Electrochemistry Instru-
ment (UEI; Department of Chemistry Electronic Shop, University
of North Carolina, Chapel Hill, NC, USA), which was computer
controlled by commercially available software (ESA Bioscience,
Chelmsford, MA, USA). The potential of the CFM was linearly
scanned at 10 Hz from a resting value of 20.4 V to 1.3 V (versus
the reference electrode) and back again at a rate of 400 V/s. The
peak oxidation current for dopamine recorded during each scan
was converted to a concentration based on post-calibration of the
CFM using flow-injection analysis in a buffer consisting of
150 mM sodium chloride with 15 mM TRIS and adjusted to a
pH of 7.4 [31]. Dopamine was identified from the background
subtracted voltammogram [32].
Electrical Stimulation
Electrical stimulation was computer generated and consisted of
biphasic pulses (2 ms each phase). Stimulus trains were applied to
a twisted bipolar stimulating electrode (Plastics One, Roanoke,
VA, USA) through a constant-current generator and optical
isolator (NL 80, Neurolog, Medical Systems, Great Neck, NY,
USA).
Data Analysis
Dopamine responses electrically evoked by short and medium
stimulations were analyzed for maximal concentration ([DA]max)
and parameters described vesicular dopamine release and
dopamine uptake according to [28]:
d DA½ =dt~ DA½ p|f{k| DA½  ð1Þ
where [DA]p is the concentration of dopamine released per
stimulus pulse, f is the frequency of stimulation, and k is the first-
order term describing dopamine uptake. Data were best fit to
Equation 1 using non-linear regression with a simplex algorithm
[29]. First-order, as opposed to Michaelis-Menten, kinetics was
selected to characterize dopamine uptake because of concern that
AMPH alters both Km and Vmax, which is difficult to resolve with
in vivo voltammetry [13,14]. However, similar AMPH-induced
changes in [DA]p, the focus of the present study, have been
reported using both kinetic models [13]. Dopamine responses
evoked by long trains were analyzed for vesicular dopamine
release using single curve analysis [29]. The reason is that
Equation 1 assumes that vesicular dopamine release is constant,
and AMPH clearly caused time-dependent changes in recordings
evoked by long trains as evident by the pronounced slowing of the
upward slope during the train, especially in the dorsal striatum. In
single curve analysis, which does not assume a kinetic mechanism
Figure 1. Experimental timeline. Three stimulation trains with
different durations (0.4 s, 2 s, and 10 s), indicated by the horizontal line
under each evoked response, were applied before and after psycho-
stimulant administration at time 0 min. Note that evoked responses are
on a second timescale, while the overall design is shown in minutes.
doi:10.1371/journal.pone.0060763.g001
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for dopamine uptake, the slope of the downward portion of the
evoked signal (i.e., uptake) is subtracted from the upward portion
(i.e., release - uptake) to calculate vesicular dopamine release:
d DA½ =dtf gupward- d DA½ =dtf gdownward~ DA½ p|f ð2Þ
The only assumption of single curve analysis regarding uptake is
that rates governing up- and downward portions are identical at
the same dopamine concentration, which is also the same
assumption as in Equation 1. It should be emphasized that
because of DAT reversal, uptake measured in the presence of
AMPH more faithfully represents net dopamine clearance, i.e., the
difference between extracellular removal by uptake and addition
by efflux [12,33]. Nevertheless, the combination of these effects is
accounted for in the analysis, which permits a direct determination
of vesicular dopamine release (i.e., [DA]p).
Non-electrically evoked changes in extracellular dopamine
representing tonic and phasic dopamine signaling were chemically
resolved from the FSCV recordings with principal component
regression (PCR) using dopamine, pH and background drift as
analytes [34,35]. For training sets, dopamine and pH changes
were obtained from the electrically evoked responses, whereas
background drift was obtained during baseline recording in the
time between stimulations. PCR was performed sequentially on 5-
min epochs. Spontaneously occurring dopamine transients were
identified and characterized with peak-finding software (Mini-
Analysis, Synaptosoft, Decatur, GA, USA).
Statistical Analysis
When appropriate, data are presented as the mean 6 SEM.
[DA]max and [DA]p were statistically analyzed using a two-way
ANOVA with drug treatment and stimulus duration as indepen-
dent variables, followed by sequential Bonferroni post hoc tests.
Effects of drug treatment on k were analyzed using a one-way
ANOVA with a Tukey’s post hoc test. Tonic dopamine levels were
statistically analyzed using a one-way ANOVA with repeated
measures. Statistical analysis was performed using SPSS Version
18 for Windows (SPSS). Significance was set at p,0.05.
Drugs
Urethane, cocaine hydrochloride, and d-amphetamine sulfate
were purchased from Sigma (St. Louis, MO, USA). All drugs were
dissolved in 150 mM NaCl prior to injection. d-amphetamine and
cocaine doses were determined by base weight.
Results
Psychostimulant effects on evoked dopamine levels
Individual recordings of electrically evoked dopamine levels
collected during the four treatments are shown in Figure 2 for the
dorsal striatum and Figure 3 for the ventral striatum. Average
results for [DA]max, the maximal concentration of the evoked
signal, and obtained from these recordings are shown in Figure 4A
(left, dorsal striatum; right, ventral striatum). Both individual
responses and averaged results demonstrate drug-, dose-, stimulus-
, and region-dependent effects, and four general observations can
be made. First, psychostimulant effects were inversely related to
stimulus duration in both striatal regions. Second, AMPH but not
cocaine decreased [DA]max evoked by the long train, and this only
occurred in the dorsal striatum. Third, AMPH was more
proficient in increasing [DA]max evoked by the short train in the
ventral striatum, whereas cocaine elicited greater effects in the
dorsal striatum. And fourth, the high dose of AMPH was more
proficient at increasing [DA]max during short trains in both striatal
regions compared to the low dose. Statistical analysis of [DA]max
revealed a significant effect of drug treatment in the dorsal
(F3,75 = 13.45, p=,0.001) and ventral (F3,74 = 8.81, p,0.001)
striatum, a significant effect of stimulus duration in the dorsal
(F2,75 = 47.94, p,0.001) and ventral (F2,74 = 13.96, p,0.001)
striatum, and a significant interaction in the dorsal (F6,75 = 8.45,
p,0.001) and ventral (F6,74 = 3.08, p,0.01) striatum. In the dorsal
striatum, 10 mg/kg AMPH and 40 mg/kg cocaine significantly
(p,0.002) increased [DA]max evoked by the short train, but only
cocaine was effective at the intermediate train (p,0.001). Both
doses of AMPH (1 and 10 mg/kg) significantly (p,0.001)
decreased [DA]max evoked by the long train, whereas cocaine
was without effect. In the ventral striatum, both doses of AMPH
and cocaine significantly (p,0.01) increased [DA]max evoked by
short and intermediate trains, but were without effect with the long
train.
Psychostimulant effects on vesicular dopamine release
and dopamine uptake
Observed psychostimulant-induced changes in [DA]max could
arise from altered vesicular dopamine release and/or dopamine
uptake, because both mechanisms regulating extracellular dopa-
mine in the striatum operate concurrently during the stimulus
train [28]. Evoked responses were therefore analyzed to determine
Figure 2. Representative psychostimulant- and stimulation-
dependent effects on evoked dopamine dynamics in the dorsal
striatum. A. Saline. B. 1 mg/kg AMPH. C. 10 mg/kg AMPH. D. 40 mg/
kg cocaine (COC). AMPH and cocaine altered the amplitude of evoked
dopamine signals in the dorsal striatum, while saline had no effect. In
contrast to cocaine, there was an inverse relationship between stimulus
duration and evoked dopamine amplitude following AMPH. Application
of the stimulus train is indicated by the solid line underneath each
representative response for short (left), intermediate (middle) and long
(right) durations.
doi:10.1371/journal.pone.0060763.g002
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the respective contributions of these presynaptic mechanisms to
[DA]max. Figure 4B shows vesicular dopamine release ([DA]p).
Overall, [DA]p and [DA]max (Fig. 4A) tracked each other well.
Statistical analysis of [DA]p revealed a significant effect of drug
treatment in the dorsal (F3,73 = 8.36, p,0.001) and ventral
(F3,72 = 6.79, p,0.001) striatum, a significant effect of train
duration in the dorsal (F2,73 = 30.45, p,0.001) and ventral
(F2,72 = 19.53, p,0.001) striatum, and a significant interaction in
the dorsal (F6,73 = 6.33, p,0.001) and ventral (F6,72 = 4.26,
p,0.001) striatum. In the dorsal striatum, 10 mg/kg AMPH and
cocaine significantly increased [DA]p for the short train (p,0.02).
1 mg/kg AMPH was without effect, and no treatment had
significant effects for the intermediate train. Both doses of AMPH
significantly decreased [DA]p for the long train (p,0.01), while
cocaine had no effect. All drug treatments significantly increased
[DA]p in the ventral striatum for both short and intermediate
trains (p,0.03) but were without effect for the long stimulation.
Psychostimulant effects on dopamine uptake are shown in
Table 1. Low- and high-dose AMPH and cocaine robustly
decreased dopamine uptake (k) to a similar degree in both striatal
regions. Statistical analysis of k revealed a significant effect of drug
treatment in both the dorsal (F3,54 = 10.53, p,0.001) and ventral
(F3,54 = 15.80, p,0.001) striatum. Each drug treatment signifi-
cantly decreased dopamine uptake compared to saline control in
both striatal regions (p,0.01). AMPH- and cocaine-mediated
uptake inhibition is consistent with our previous work using
Michaelis-Menten kinetics [12,29,31], and the degree of inhibition
was similar to our previous work using first-order kinetics [14], as
is used here. This result, indicating no distinct effects of drug
treatment or striatal region on dopamine uptake, and the excellent
correspondence between [DA]max and [DA]p shown in Figure 3,
suggest that psychostimulant-induced changes in [DA]max evoked
by the trains used in this study are dominated by changes in
vesicular dopamine release. The one overt exception is the
intermediate train in the dorsal striatum, where cocaine increased
[DA]max without a corresponding change in [DA]p. In this case,
reduced dopamine uptake dominates the increase in [DA]max.
Overall, these results demonstrate that AMPH and cocaine
increase vesicular dopamine release in both striatal regions with
the short train but that AMPH decreases vesicular dopamine
release in the dorsal striatum with the long train.
Psychostimulant effects on tonic dopamine signaling
Figure 5 shows a representative background-subtracted FSCV
recording (black) collected immediately surrounding the time of
injecting high-dose AMPH. This non-electrically evoked trace,
representing current measured at the peak oxidative potential for
dopamine (i.e., along the horizontal white line of the pseudocolor
plot below), gradually increases across the 5-min epoch. Individual
voltammograms collected along the two vertical white lines of the
pseudocolor plot (blue) are overlaid with a dopamine voltammo-
gram collected during electrical stimulation (black) earlier in this
recording (data not shown). While there is evidence for dopamine
in the individual voltammograms and in the sequential voltammo-
grams displayed in the pseudocolor plot for this non-electrically
evoked trace, other analytes obscure its selective measurement
with FSCV alone. However, PCR (red) resolves the dopamine
component of this FSCV recording, demonstrating an activation
of tonic dopamine signaling by AMPH.
Figure 3. Representative psychostimulant- and stimulation-
dependent effects on evoked dopamine dynamics in the
ventral striatum. A. Saline. B. 1 mg/kg AMPH. C. 10 mg/kg AMPH.
D. 40 mg/kg cocaine (COC). AMPH and cocaine increased evoked
dopamine amplitude for at stimulus durations in the ventral striatum,
while saline had no effect. Application of the stimulus train is indicated
by the solid line underneath each representative response for short
(left), intermediate (middle) and long (right) durations.
doi:10.1371/journal.pone.0060763.g003
Figure 4. Averaged psychostimulant- and stimulation-depen-
dent effects. A. The maximal concentration of electrically evoked
dopamine ([DA]max). B. Vesicular release ([DA]p). Stimulus duration is
shown along the x axis. Psychostimulants differentially elicited stimulus-
dependent effects on [DA]max and [DA]p. Data are the ratio of post-drug
over pre-drug response (Post/Pre) for the dorsal (left) and ventral (right)
striatum and are expressed as mean 6 SEM. *, significantly different
from saline (p,0.05).
doi:10.1371/journal.pone.0060763.g004
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Figure 6 shows the average effects of the four treatments on
tonic dopamine signaling as determined by PCR analysis for the
first 10 min of the FSCV recording after drug injection, which is
just prior to the first stimulation of the post-drug period (see Fig. 1).
This initial recording period was selected for analysis to avoid
interactions between stimulation, psychostimulants, and tonic
dopamine signaling. In the dorsal striatum (Fig. 6A), AMPH
(10 mg/kg) elicited the fastest and largest increase in tonic
dopamine levels. Statistical analysis revealed a significant effect
of treatment (F3,22 = 3.38, p=0.04), time (F4,22 = 11.99, p,0.001),
and interaction (F12,22 = 2.13, p=0.03). A post hoc comparison of
the average change across the last two minutes of the time course
(INSET) revealed that only 10 mg/kg AMPH significantly
increased tonic dopamine levels compared to saline (p,0.01). In
the ventral striatum (Fig. 6B) region, the effects of each
psychostimulant were largely indistinguishable from each other
and only slightly different than the saline control. Statistical
analysis revealed a significant effect of only time (F4,22 = 3.90,
p=0.02). Overall, these results suggested that AMPH is more
effective at increasing tonic dopamine signaling than cocaine and
in the dorsal compared to the ventral striatum initially after drug
injection.
Psychostimulant effects on phasic dopamine signaling
Increased [DA]max of phasic-like dopamine responses evoked by
the short train (Figs. 2, 3, 4) suggests that both amphetamine and
cocaine activate phasic dopamine signaling. These results are thus
consistent with the two psychostimulants augmenting naturally
occurring dopamine transients in awake, freely behaving animals
[13,36,37]. While psychostimulant-induced burst firing of dopa-
mine neurons is typically blunted under anesthesia [38] unless
revealed by D2 antagonists [9,10], dopamine transients are elicited
by AMPH in a subset of animals in this preparation [14]. An
example of this activation is shown in Figure 7. Before drug
injection, the dopamine response evoked by the short train was
small and no dopamine transients were observed (Fig. 7A). In
sharp contrast, high-dose AMPH dramatically increased this
evoked phasic-like signal, mediated by augmented vesicular
dopamine release and inhibited dopamine uptake (Fig. 4 and
Table 1), and transient frequency (Fig. 7B). To better view the
presence or absence of dopamine transients, FSCV recordings are
expanded in the INSET. These short-lived, non-electrically
evoked deflections were identified as dopamine by the sequential
voltammograms displayed in the pseudocolor plot below each
trace and by the overlay of the individual voltammogram for the
transients (black) with that obtained from the evoked signal
established to be dopamine (red) to the left in the INSET.
To complement evoked phasic-like responses, we thus analyzed
these dopamine transients to obtain a more physiological
assessment of psychostimulant effects on phasic dopamine
signaling. Figure 8 shows the time course of dopamine transients
for high-dose AMPH (Panel A) and cocaine (Panel B) in the dorsal
and ventral striatum (top and bottom, respectively) in the subset of
animals where this phasic activity was observed (see legend for
details). Transients were analyzed for frequency (left), amplitude
(middle), and duration (right). Time 0 min is drug injection. The
time when short, intermediate and long trains were applied during
the post-drug period is demarcated by vertical dashed lines at 10,
12 and 22 min, respectively. High-dose AMPH and cocaine
activated dopamine transients in both striatal subregions. Tran-
sients were rarely observed during pre-drug recording and were
not observed after saline or low-dose AMPH. Both psychostim-
ulants increased the frequency of dopamine transients to a greater
extent in the ventral compared to the dorsal striatum, and AMPH
was more effective than cocaine in both striatal subregions. The
Table 1. Psychostimulant effects on dopamine uptake.
Saline AMPH (1 mg/kg) AMPH (10 mg/kg) Cocaine (40 mg/kg)
Dorsal 0.9660.05 0.5760.04** 0.5360.08** 0.6660.06**
Ventral 0.9560.04 0.6260.05** 0.5060.08** 0.6060.05**
Data are the mean 6 SEM.
**, significantly different from saline (p,0.01).
doi:10.1371/journal.pone.0060763.t001
Figure 5. Representative effects of AMPH on tonic dopamine
levels in the dorsal striatum. The black line (left y axis) in the top
panel shows background-subtracted current, and pseudocolor plot
underneath displays all background-subtracted cyclic voltammograms
immediately following administration of the high dose (10 mg/kg) of
AMPH. Current, which was measured at the peak oxidative potential for
dopamine (horizontal white line on the pseudocolor plot), was
converted to dopamine concentration (red line, right y axis) using
PCR. INSET. Background-subtracted cyclic voltammograms taken at
150 s and 250 s (blue arrows, blue line) and from the post-drug
electrically evoked (60 Hz, 0.4 s) dopamine signal (black line).
doi:10.1371/journal.pone.0060763.g005
Amphetamine Effects on Dopamine Pools
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Figure 6. Averaged psychostimulant-induced increases in tonic dopamine levels. A. Time course of the effects of AMPH and cocaine (COC)
on tonic dopamine levels. Dopamine concentrations were determined using PCR and averaged across 10-s bins. The time period is the epoch
immediately following drug injection and prior to the first post-drug. B. Dopamine levels from A. above but only shown at two-minute intervals.
These data were used for statistical analysis. Data in the dorsal (left) and ventral (right) striatum are expressed as mean6 SEM. *, significantly different
from other treatments (p,0.05).
doi:10.1371/journal.pone.0060763.g006
Figure 7. Representative effects of AMPH on phasic dopamine signaling in the ventral striatum. A. Pre-drug. B. Post-AMPH. Traces show
90 s of a recording with a short-duration (0.4 s) stimulation applied at 5 s (see line underneath). The color plot serially displaying all background-
subtracted cyclic voltammograms is shown underneath. INSET. Time-expanded view. Individual background-subtracted voltammograms are shown
at the top left and compare dopamine collected during the evoked phasic-like response (black line) to pre-drug baseline (A.) or a dopamine transient
collected post-drug (B.) as indicated by vertical white line in the pseudocolot plot (red line).
doi:10.1371/journal.pone.0060763.g007
Amphetamine Effects on Dopamine Pools
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onset of dopamine transient activation was also slower for cocaine.
A clear inhibition and rebound in transient frequency was
observed following the long train in both the dorsal and ventral
striatum after AMPH. This effect is most likely related to feedback
inhibition by released dopamine [39], with the additional
combination of AMPH and the long train depleting vesicular
dopamine release in the dorsal striatum (Fig. 4). Overall, results for
dopamine transients are consistent with those for evoked phasic-
like responses and suggest that AMPH and cocaine activate phasic
dopamine signaling.
Discussion
The goal of the present study was to reconcile the paradoxical
effects of AMPH on dopamine neurons. To this end, we tested the
novel hypothesis that AMPH depletes the reserve pool but up-
regulates the readily releasable pool. This hypothesis was
formulated based on three key observations reported in the
literature. First, dopamine neurons contain distinct vesicular
storage pools. Second, different train durations interrogate
different vesicular storage pools. And third, AMPH effects on
electrically evoked dopamine levels in the dorsal striatum appear
inversely related to train duration. We tested this hypothesis using
a novel experimental design. When taken together, our results
support a model of AMPH activating tonic dopamine signaling by
depleting the reserve pool to drive non-exocytotic efflux, but
activating phasic dopamine signaling by up-regulating the readily
releasable pool to drive vesicular dopamine release.
Experimental Design
Four features highlight the utility of the experimental design.
First, different train durations, selected to demonstrate stimulus-
dependent AMPH effects, were applied to the same animal.
Although this strategy fosters inter-animal comparisons, it also
risks train interactions because dopamine release depends upon
stimulation history [40]. However, stability of the saline control
and replicating stimulus-dependent AMPH effects demonstrated
previously in separate animals indicated that judicial spacing of
trains was sufficient to minimize interaction. Second, evoked
dopamine dynamics were resolved into the respective contribu-
tions of vesicular release and uptake. Most previous studies
examining stimulus-dependent AMPH effects report dopamine
levels only and therefore do not directly assess release. Third, the
status of dopamine storage pools was related to tonic and phasic
dopamine signaling. Such an integrated view of AMPH action has
not been available. And fourth, we compared AMPH to cocaine,
which is recognized to inhibit DAT and increase vesicular release,
but not to deplete vesicular stores in vivo.
Figure 8. Averaged effects of psychostimulants on dopamine transients. A. AMPH. B. Cocaine. Dopamine transients were analyzed in terms
of frequency (left), amplitude (middle) and duration (right) in both the dorsal and ventral striatum (DS and VS, respectively). Data are transient
characteristics compiled into 60-s bins and express as the mean6 SEM. Each histogram shows transient characteristics for the 10 minutes before, and
the 65 minutes after drug injection (at time 0 min). Phasic dopamine transients were observed following AMPH in 3 of 7 animals in the dorsal
striatum and 5 of 7 in the ventral striatum and following cocaine in 3 of 7 animals in the dorsal striatum and 1 of 7 animals in the ventral striatum.
doi:10.1371/journal.pone.0060763.g008
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AMPH enhances tonic and phasic dopamine signaling
Tonic dopamine signaling, which is characterized by a steady-
state basal level of dopamine and controlled by slow irregular
firing of dopamine neurons and presynaptic input [41], enables
movement, cognition and motivation [15]. AMPH robustly
increases tonic dopamine levels measured by microdialysis [6],
but comparatively greater elevations in dialysate dopamine relative
to other DAT-inhibiting psychostimulants such as cocaine [5] are
attributed to the unique action of AMPH eliciting non-exocytotic
efflux [7,8]. We show here that only high-dose AMPH increased
tonic dopamine levels and this only occurred in the dorsal
striatum. Analytical differences between measurement techniques
may have contributed to discrepancies between the present
measures with FSCV and microdialysis studies [42]. While FSCV
excels at fast measurements with a small probe, inherent
limitations in selectivity require the use of statistical methods such
as PCR to resolve the dopamine component of tonic changes [34].
Microdialysis exhibits superior selectivity but suffers from implan-
tation damage due to the considerably larger probe that
overestimates the increase in tonic dopamine levels with dopamine
uptake inhibitors [42]. Thus, measurements of tonic dopamine
levels using both approaches should be carefully scrutinized. We
should also emphasize that a conservative approach with FSCV
was used to minimize error, by only characterizing the first 10-min
post-drug epoch and by incorporating background drift as a PCR
component [35]. Increases in tonic dopamine levels may thus have
occurred after this time. Another consideration when comparing
the present and microdialysis studies is anesthesia, which inhibits
dopamine neuron firing [43]. However, observed effects of saline
and low- and high-dose AMPH on tonic dopamine levels are
consistent with un-anesthetized recordings [13]. The contribution
of efflux to AMPH-induced increases in tonic dopamine levels
measured by FSCV and observed here and elsewhere [13,14] has
not been determined. However, efflux is implicated using the
present experimental design because increased tonic levels are
associated exclusively with vesicular depletion.
Phasic dopamine signaling, in which burst firing of dopamine
neurons generates sub-second changes in extracellular dopamine
called transients [44], is important for goal-directed behavior and
reinforcement learning [15]. Cocaine activates burst firing [38],
the amplitude, frequency and duration of naturally occurring
dopamine transients [36,37], and evoked phasic-like dopamine
responses [14,45]. AMPH has also been shown to augment evoked
phasic-like dopamine responses, as well as spontaneously occurring
and cue-evoked dopamine transients [13,14]. Consistent with
these previous studies, we show here that both AMPH and cocaine
activated evoked phasic-like dopamine responses and dopamine
transients. Anesthesia likely attenuated these effects by inhibiting
burst firing [43] and phasic activation by psychostimulants
[13,14,37,38,46]. However, awake, freely behaving animals do
not tolerate intermediate and long stimulus trains, so anesthesia is
required to assess recycling and reserve pools.
Stimulus-dependent effects of AMPH on [DA]max
The present results, obtained by applying different train
durations to the same animal, are consistent with previous work
applying these same trains individually in separate animals. For
example, in the presence of AMPH and in the dorsal striatum, the
long train decreased [DA]max [25,47,48], the intermediate train
elicited minimal to no effect [11,12], and the short train increased
[DA]max [13,14]. Similar results were obtained in the ventral
striatum, except that the long train did not decrease [DA]max,
which is also consistent with previous work [48]. We additionally
extend these studies by comparing AMPH effects to cocaine,
which only elicited increases or no change in [DA]max, and by
determining the underlying change in vesicular dopamine release,
which permits analysis of storage pools. Indeed, because both
AMPH and cocaine robustly inhibit dopamine uptake (Table 1,
[12–14,31,33,49]), observed alterations in [DA]max have a
complex origin.
AMPH elicits opposing actions on readily releasable and
reserve pools for dopamine
Work with model synapses indicates that readily releasable,
recycling, and reserve pools of neurotransmitters are interrogated
by short, intermediate, and long duration trains, respectively [16].
We used this approach to investigate the effects of AMPH on
dopamine stores. In the dorsal striatum, each stimulus train
elicited a distinct action on vesicular dopamine release in the
presence of high-dose AMPH: increase, no change, and decrease
for short, intermediate, and long trains, respectively. Taken
together, these results suggest that AMPH augments the readily
releasable pool, exerts no effect on the recycling pool, and depletes
the reserve pool in the dorsal striatum. By contrast, the readily
releasable pool and to a lesser extent the recycling pool were up-
regulated without depletion of the reserve pool by AMPH in the
ventral striatum and cocaine in both striatal sub-regions. As a
psychostimulant with multiple actions, AMPH could augment
vesicular dopamine release by several mechanisms, such as: (1)
inhibiting monoamine oxidase [50] and activating tyrosine
hydroxylase [51], leading to greater cytosolic dopamine levels,
vesicular packaging, and ultimately quantal size; (2) increasing
membrane excitability as a DAT substrate [52]; and (3) enhancing
exocytosis by liberating vesicular Ca2+ stores [53]. Depleting the
reserve pool suggests another mechanism, re-distributed cytosolic
dopamine being re-packaged by the readily releasable pool. This
latter postulate is supported by the greater capacity of this vesicle
population to sequester cytosolic dopamine [54,55]. Moreover,
robust depletion of vesicular dopamine stores by AMPH, well
established using reduced preparations [21,22,53,56–61], appears
to occur independently in separate classes of dopamine vesicles
[21,22]. Depletion involves AMPH acting as a weak base to
destabilize the proton gradient across vesicles and as a substrate of
the vesicular monoamine transporter to inhibit and/or reverse its
action [7,8]. How these mechanisms might differ across dopamine
storage pools, as our results would suggest, remains to be
determined.
We also do not know why AMPH depleted vesicular dopamine
stores in the dorsal but not ventral striatum. One possible origin is
regional differences in DAT. For example, DAT binding and Vmax
for dopamine uptake are higher in the dorsal striatum [62,63], and
DAT is more glycosylated with a higher molecular weight in the
ventral striatum [64]. Although Km for dopamine uptake is similar
in the two regions [31,63], AMPH is a more potent competitive
inhibitor of dopamine uptake in the dorsal compared to the
ventral straitum [12]. We are not aware of comparable regional
differences in the vesicular monoamine transporter. Another
possible origin is regional differences in vesicular dopamine stores.
As mentioned above, different classes of dopamine vesicles exhibit
different sensitivities to the depleting actions of AMPH [21,22].
Consistent with region-specific actions of AMPH on vesicular
dopamine stores, we have recently shown that AMPH may up-
regulate vesicular dopamine release in the ventral striatum by
mobilizing the reserve pool but by activating dopamine synthesis
and inhibiting dopamine degradation in the dorsal striatum [65].
Different distributions of small, clear and large, dense-core vesicles
in the two striatal sub-regions [66] may also contribute to the
differential response to AMPH. Clearly, more work needs to be
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done to resolve the differential depleting effects of AMPH on
dopamine vesicles in the dorsal and ventral striatum.
New model of amphetamine action
We propose a new model of AMPH action: activating tonic
dopamine signaling by depleting the reserve pool, which elevates
cytosolic dopamine and drives reverse transport through DAT,
while concurrently activating phasic dopamine signaling by up-
regulating the readily releasable pool, which drives vesicular
dopamine release. This model is supported here by the first report
of a selective coupling between tonic activation and vesicular
depletion coincident with phasic activation and up-regulated
vesicular release. Revealing this unique combination of AMPH
effects underscores the utility of the experimental design employed.
Indeed, slice voltammetry has demonstrated a parallel between
robust vesicular depletion and micromolar dopamine efflux, but
no measures of phasic signaling or its release component were
examined [58,60,61]. Moreover, in vivo voltammetry has demon-
strated concurrent activation of tonic and phasic dopamine
signaling and up-regulated vesicular release, but effects on the
reserve pool were not assessed [13,14]. Further supporting our
proposed model is that, in contrast to AMPH in the dorsal
striatum, AMPH in the ventral striatum and cocaine in both
striatal sub-regions did not deplete vesicular stores or elevate tonic
dopamine levels, despite phasic activation and up-regulated
vesicular release.
Two confounds need addressing. First, coupling between tonic
activation and vesicular depletion was not observed for low-dose
AMPH in the dorsal striatum. It could be that, while cytosolic
dopamine increased as a result of vesicular depletion, low-dose
AMPH was insufficient to inhibit monoamine oxidase and prevent
its intracellular degradation and/or to reverse DAT direction and
cause efflux. Both AMPH effects are dose-dependent [50,67]. Also
consistent with this interpretation is that vesicular depletion alone
does not elicit efflux [58] and that both vesicular depletion and
blockade of monoamine oxidase are required for cytosolic levels to
increase [59]. In contrast, there are other reports demonstrating
that increases in cytosolic dopamine alone are sufficient to induce
efflux [44,68]. Second, low-dose AMPH also did not activate
phasic dopamine signaling or vesicular dopamine release in the
dorsal striatum. However, this lack of response is an anesthesia
artifact, because both are enhanced in awake, freely behaving
animals [13].
Implications for psychostimulant neurobiology
We demonstrate fundamentally similar and distinct mechanisms
for two major classes of psychostimulants, AMPH representing the
so-called dopamine ‘‘releasers’’ (i.e., eliciting non-exocytotic efflux)
and cocaine representing the DAT ‘‘inhibitors’’ [33]. While
AMPH and cocaine share phasic activation through augmented
vesicular dopamine release (Fig. 4, [13,14,45,49,69–71]) and
enhanced burst firing [9,10,38], they differ in tonic activation. In
particular, cocaine requires action potential-dependent mecha-
nisms whereas AMPH does not [72–74]. Inhibition of dopamine
uptake (Table 1, [12–14,31,33,49]) would contribute to augment-
ed tonic and phasic signaling by both psychostimulants. However,
activation of vesicular dopamine release may be more important
than uptake inhibition, especially for phasic signaling, because
release better tracks [DA]max (Fig. 4, [13]).
The neurobiological implications of these psychostimulant
actions are not presently known, but they could be profound.
Several drugs of abuse have now been demonstrated to augment
dopamine transients, including amphetamine, cocaine, nicotine
and ethanol [13,37,46,75,76]. The greater activation of phasic
dopamine signaling by abused drugs compared to natural rewards
and the subsequent usurpation of normal reward processing to
promote addiction [77] may thus represent a unifying mechanism.
While both classes of psychostimulants would promote reinforce-
ment learning by activating the direct (‘‘Go’’) pathway in the basal
ganglia via enhanced phasic signaling and D1 receptor binding,
AMPH would more robustly inhibit the indirect (‘‘No Go’’)
pathway (i.e., disinhibition of behavior) via enhanced tonic
signaling and D2 receptor binding [78], because of the added
contribution of non-exocytotic efflux. Future directions should also
investigate how intrastriatal differences in AMPH action relate to
the diverse roles of dopamine signaling in this region for
promoting drug reinforcement and addiction [79,80].
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